Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria

OBJECTIVE: Concomitant treatment with angiotensin-converting enzyme (ACE) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors is increasingly common. Pharmacological studies have suggested a potential adverse drug interaction between ACE inhibitors and DPP-4 inhibitors resulting in unfavorable...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Mark E., Perkovic, Vlado, Groop, Per-Henrik, Hocher, Berthold, Hehnke, Uwe, Meinicke, Thomas, Koitka-Weber, Audrey, van der Walt, Sandra, von Eynatten, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
ORIGINAL PAPERS: Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513080/
https://www.ncbi.nlm.nih.gov/pubmed/30540657
http://dx.doi.org/10.1097/HJH.0000000000002032

Ejemplares similares

Ejemplares similares